Related Experiment Video
Updated: Jul 14, 2026

Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension
Published on: April 11, 2016
Pathophysiology of pulmonary arterial hypertension
Suma Jain1, Hector Ventura, Ben deBoisblanc
1Section of Pulmonary/Critical Care Medicine, Ochsner Foundation Clinic, Jefferson, USA.
Pulmonary hypertension involves complex pathways causing increased pulmonary vascular resistance. Endothelial dysfunction is key to structural changes, regardless of the cause.
Area of Science:
- Cardiovascular Medicine
- Pulmonary Medicine
- Pathology
Background:
- Pulmonary hypertension (PH) involves elevated precapillary pulmonary vascular resistance.
- PH pathogenesis is complex, involving multiple pathways.
- Histopathologic findings include neoangiogenesis, smooth muscle proliferation, vasoconstriction, and thrombosis.
Purpose of the Study:
- To elucidate the complex mechanisms and histopathologic findings in pulmonary hypertension.
- To highlight the role of endothelial dysfunction in mediating structural changes in PH.
Main Methods:
- Review of histopathologic findings in pulmonary hypertension.
- Analysis of mechanisms contributing to increased pulmonary vascular resistance.
- Examination of endothelial function in various etiologies of PH.
Main Results:
- Key histopathologic sequelae identified: neoangiogenesis, intimal and smooth muscle proliferation, vasoconstriction, and in situ thrombosis.
- Endothelial dysfunction is a common finding across diverse causes of pulmonary hypertension.
- Endothelial dysfunction is implicated as a central mediator of structural vascular remodeling in PH.
Conclusions:
- The structural changes in pulmonary hypertension, while diverse in origin, share common histopathologic features.
- Endothelial dysfunction is a critical unifying factor in the development of pulmonary hypertension, irrespective of the initial trigger.
- Targeting endothelial dysfunction may offer therapeutic strategies for pulmonary hypertension.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Hypertension II: Pathophysiology
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Peripheral Artery Disease I: Introduction

